Avoro Capital Advisors LLC increased its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,260,900 shares of the biotechnology company’s stock after buying an additional 10,900 shares during the quarter. […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Rocket Pharmaceuticals […]
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) insider John Militello sold 1,079 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $23.35, for a total transaction of $25,194.65. Following the completion of the sale, the insider now owns 53,327 shares of the […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) General Counsel Martin Wilson sold 1,048 shares of Rocket Pharmaceuticals stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.35, for a total transaction of $24,470.80. Following the completion of the transaction, the general counsel now directly owns 65,762 […]